Increase in the immunogenicity of HIV peptide antigens by chemical linkage to polytuftsin (TKPR40)

DNA and Cell Biology

Volumn 18, Issue 8, 1999, Pages 623-630

  Gokulan, Kuppan ^a,b   Khare, Sangeeta ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; SYNTHETIC PEPTIDE; TUFTSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; CELLS, CULTURED; CYTOKINES; DIMERIZATION; DRUG CARRIERS; HAPLOTYPES; HIV; HIV ANTIBODIES; HIV ANTIGENS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MACROPHAGES; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED STRAINS; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; POLYMERS; T-LYMPHOCYTES; TUFTSIN;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032783666     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454999315033     Document Type: Article

References (36)

1. ANDERSON, P., PICHICHERO, M., EWARDS, K., and PORCH, C.R. (1987). Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20 and oligosaccharide-protein conjugate vaccines. J. Pediatri. 111, 644-650.
2. AHULUWALIA, A., GOKULAN, K., NATH, I., and RAO, D.N. (1997). Modification of delivery system enhances MHC nonrestricted immunogenicity of V3 loop region of HIV gp120. Microbiol. Immunol. 41, 779-784.
3. AVRAMEAS, S., and TERNYNCK, T. (1969). The cross linking of proteins with glutaraldehyde and its use for the preparation of immunosorbents. Immunochemistry 6, 53-66.
4. BELL, S.J., COOPER, D.A., KEMP, B.E., DOHERTY, R.R., and PENNY, R. (1992). Definition of an immunodominant T-cell epitope contained in the envelope gp41 sequence of HIV-1. Clin. Exp. Immunol. 87, 37-45.
5. BOYUM, A. (1968). Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 21, 77-89.
6. CORAZZA, G.R., ZOLI, G., GINALDI, L., CANCELLIREI, C., PROFETA, V., GASBARRINI, G., and QUAGLINO, D. (1991). Tuftsin deficiency in AIDS. Lancet 337, 13.
7. DEVI, R., GOKULAN, K., and RAO, D.N. (1995). Polytuftsin enhances the immunogenicity of peptide variants of circumsporozoite protein of Plasmodium vivax. J. Parasitic Dis. 19, 117-122.
8. EY, P.L., PROWSE, S.J., and JENKIN, C.R. (1979). Complement-fixing IgG1 constitutes a new subclass of mouse IgG. Nature 281, 492-499.
9. GALLO, R.C., SALAHUDDIN, S.Z., POPOVIC, M., SHEARER, G.M., KAPLAN, M., HAYNES, B.F., PALKER, T.J., REDFIELD, R., OLESKE, J., and SAFAI, B. (1984). Frequent detection and isolation of cytopathic retrovirus (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
10. GOKULAN, K., TRIPATHI, S.P., and RAO, D.N. (1997). Advantage of dimeric peptide antigens in serodiagnosis of HIV-1 infection. Microbiol. Immunol. 41, 215-220.
11. HUNTER, R., OLSEN, M., and BUYNITZKY, S. (1991). Studies on non-ionic block copolymer adjuvants IV: effect of molecular weight of formulation on titre and isotype of antibody. Vaccine 9, 250-256.
12. IVANOV, B.B., MESHCHERYAKOVA, E.A., ANDRONOVA, T. M., and IVANOV, V.T. (1994). Dituftsin and polytuftsin induce an antipeptide IgG response to non-immunogenic peptides in mice. Immunol. Invest. 23, 201-212.
13. KALISH, M.L., CHECK, I.J., and HUNTER, R.L. (1991). Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5 I: effects of carrier, copolymer adjuvants and lipopolysaccharide on isotype selection. J. Immunol. 146, 3583-3590.
14. KHARE, S., BHUTANI, L.K., and RAO, D.N. (1993). Modulation of peripheral blood derived monocytes/macrophages from leprosy patients using "tuftsin" for production of reactive oxygen intermediates. Lepr. Rev. 64, 208-218.
15. KIRONDE, F.A.S., RAO, K.V.S., SHAH, S., KUMAR, A., and SAHOO, N. (1991). Towards the design of heterovalent anti-malaria vaccine: a hybrid immunogen capable of eliciting immune responses to epitopes of circumsporozoite antigens from two different species of malaria parasite, Plasmodium. Immunology 74, 323-338.
16. KUMAR, P. IVANOV, B.B., KABILAN, L., and RAO, D.N. (1994). Construction of synthetic immunogen: use of the natural immunomodulator "polytuftsin" in malarial vaccine against RESA antigen of Plasmodium falciparum. Vaccine 12, 819-824.
17. LASKY, L.A., NAKAMURA, G., SMITH, D.H., FENNIE, C., SHIMASAKI, C., PATZER, E., BERMAN, P., GREGORY, T., and CAPON, D.J. (1987). Delineation of a region of human immunodeficiency virus type-1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50, 975-985.
18. LOWELL, G.H., SMITH, L.J., SEID, B.S., and ZOLLINGER, W.D. (1988). Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. J. Exp. Med. 167, 658-663.
19. MERRIFIELD, R.B.J. (1963). Solid phase peptide synthesis. J. Am. Chem. Soc. 85, 2149-2154.
20. MODROW, S., HAHN, B.H., SHAW, G.M., GALLOW, R.C., WANGSTAAL, F., and WOLF, H. (1987). Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61, 570-578.
21. MOREIN, B., SUNDQUIST, B., HOGLUND, S., DALSGARD, K., and OSTERHAUS, A. (1984). ISCOM, a novel structure for antigenic presentation of membrane proteins from enveloped virus. Nature 308, 457-460.
22. PALKER, T.T., MATHEWS, T.J., CLARK, M.E., CIANICOLO, G.R., RANDALL, R.R., LADLOIS, A.J., WHITE, C.G., SAFI, B., and SNYDERMANN, B.F. (1987). A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc. Natl. Acad. Sci. USA 84, 2479-2483.
23. RITU, G., and RAO, D.N. (1991). Construction of synthetic immunogens: use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum. Vaccine 10, 761-765.
24. SIEMION, I.Z., SLON, J., NAWROCKA, E., and WIECZOREK, Z. (1990). Competition between tuftsin and HBV s-protein sequences. Int. J. Pept. Protein Res. 35, 428-433.
25. SINIGAGLIA, F., GUTTINGER, M., KILGUS, J., DORAN, B.M., MATILE, H., ETLINGER, H.M., TRZECIAK, A., GILLESSEN, D., and PINK, J.R.L. (1988). A malaria T-epitope recognized in association with most mouse and human MHC class-II molecules. Nature 336, 778-780.
26. SNAPPER, C.M., and PAUL, W.E. (1987). Interferon-γ and B cell stimulatory factor-1 reciprocally regulate IgG isotype production. Science 236, 944-947.
27. STEWARD, M.W., and HOWARD, C.R. (1987). Synthetic peptides: a next generation of vaccines? Immunol. Today 8, 51-58.
28. SURKIS, R., RUBINROUT, D., DATAN, S., TZEHORAL, E., FRIDKIN, M., BEN-YOSEPH, R., and CATANE, R.A. (1990). Potential precursor for slow release of the phagocytosis stimulating peptide tuftsin. Int. J. Biochem. 22, 193-195.
29. SZKARADKIEWICZ, A. (1992). Phagocytosis and microbicidal capacity of human monocytes in the course of HIV infection. Immunol. Lett. 33, 145-150.
30. TAKEDA, A., TUAZON, C.U., and ENNIS F.A. (1988). Antibody enhanced infection by HIV-1 via Fc receptor mediated entry. Science 242, 580-584.
31. TAKAYAMA, K., OSLEN, M., DATTA, P., and HUNTER, R.L. (1991). Adjuvant activity of non-ionic block co-polymer. Vaccine 9, 257-267.
32. TRUDELLE, Y., BRACKS, A., DELMAS, A., PEDOUSSANT, S., and RIVAILLE, P. (1987). Synthesis of new carrier for immunization: polytuftsin. Int. J. Pept. Protein Res. 30, 54-56.
33. TZEHOVAL, E., SEGAL, S., STABINSKY, Y., FRIDKIN, M., SPIRER, Z., and FELDMAN, M. (1978). Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic functions of macrophages: implications for activation of programmed cells. Proc. Natl. Acad. Sci. USA 75, 3400-3404.
34. WEINHOLD, K.J., LYERLY, H.K., STANLEY, S.D., AUSTIN, A.A., MATTHEWS, T.J., and BOLOGNESI, D.P. (1989). HIV-I gp120 mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142, 3091-3097.
35. WIT, D.D., MECHELEN, M.B., RYELANDT, M., FIGUAIREDO, A.C., ABRAMOWICZ, D., GOLDMAN, M., BAZIN, H., URBAIN, J., and LEO, O. (1992). The injection of deaggregated gamma globulins in adult mice induces antigen specific unresponsiveness of T-helper type 1 but not type 2 lymphocytes. J. Exp. Med. 175, 9-14.
36. WU, F., GARCIA, J.A., HARRICH, D., and GAYNOR, R.B. (1986). Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. EMBO J. 7, 2117-2129.